TrialAutopsyBuilt by Jawad Momani (Pwnedl0l)

Autopsy report · NCT01755702

Paracetamol With Caffeine to Treat Episodic Tension Type Headache

Cause of deathSlow enrollment Automatic label, confidence 0.9, unverified. How labels are made.
“Study was terminated due to unforeseen difficulties with subject recruitment. No safety issues were identified in the study with this new formulation.”

The sponsor’s own words in the registry.

Life of this trial

20092010201120122013201420152016Started2009-07Stopped2010-03Registered2011-06-23Results posted2015-03-27

Vital statistics

Status
Terminated
Phase
Phase 2, Phase 3
Sponsor
GlaxoSmithKline
Sponsor type
Industry
Conditions
Headache, Tension-Type
Interventions
Placebo; Experimental paracetamol + caffeine formulation; ibuprofen marketed formulation; Paracetamol marketed formulation
Participants
66
Sites
7
Countries
United States

Trials that died the same way

Look deeper

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.